Research programme: serotonin 6 receptor antagonists - BTG
Alternative Names: 5-HT6 antagonists - BTGLatest Information Update: 21 Aug 2019
At a glance
- Originator BTG
- Class
- Mechanism of Action Serotonin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders; Obesity
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 07 May 2007 No development reported - Preclinical for Cognition disorders in United Kingdom (unspecified route)
- 07 May 2007 No development reported - Preclinical for Obesity in United Kingdom (unspecified route)